Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

Title
Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 14, Issue 6, Pages 1797-1803
Publisher
American Association for Cancer Research (AACR)
Online
2008-03-18
DOI
10.1158/1078-0432.ccr-07-1364

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now